|
4 (first) 10 20 30 40 50 60 70 80 90 99 (last) |
| R4
|
Evidence-based medicine meets patient-centredness:
is it a case of the Titanic
meeting the iceberg?
C. Morecroft, J. Cantrill, M. P. Tully and M. Crossley |
| R5
|
Explanations for inequalities in
health among people of south Asian origin living
in the UK: the views of pharmacists
Harsha Puri, Paul Bissell and Claire Anderson |
R6
|
Patient views of pharmacist-led
medication review clinics: a preliminary qualitative study
F. MacRae, R. Lowrie, A. MacLaren, S. Kinn and A. Fish
|
| R7
|
Evaluation of “Care at the pharmacy” in Gwent on the management of self limiting conditions and workload of a general medical practice
Roger Walker, Sian Evans and Diane Kirkland |
| R8
|
Pharmacist domiciliary visiting:
review of English services
D. Bhattacharya, D. J. Wright and J. R. Purvis |
| R9
|
Examining alternatives for the remuneration
of community pharmacy
A. M. Grant, C. M. Bond, J. Inch and A. Scott |
| R10
|
Opportunistic screening for type
2 diabetes within inner city community pharmacies
A. G. Lawal, M. G. Patel, I. C. K. Wong and H. Chrystyn |
| R11
|
Student perceptions of pharmacy
ethics
Joy Wingfield, Paul Bissell and Stacey Sadler |
| R12
|
Effectiveness of providing advice
only versus advice plus simple analgesia in preventing pain following
routine dental extraction under anaesthesia in children
L. Neely, J. Monkman, R. G. Hargreaves, B. Lacey, J. Law, G. Roberts, S.
Wiston, M. Ledger-Scott and K. Holden |
| R13
|
Users’ views about and compliance with rectally administered medicines
Rory J. Towler, Jonathan Silcock, D. K. Raynor, Helen Brooks and Paul Moayyedi |
| R14
|
The pharmacist-led diabetic clinic
improves glycaemic control in insulin-requiring type 2 diabetic patients:
a randomised study
L. B. M. Tadros, M. Ledger-Scott, D. Stead, Aidan King, Edward Barnes,
Matthew Malloy, Shirley Pearson and Diane Nayman |
| R15
|
Indicators for preventing drug-related
morbidity:application in general practice
C. J. Morris, S. Rodgers, V. Hammersley, A. J. Avery and J. A. Cantrill |
| R16
|
Safety profile of celecoxib as used
in general practice in England: results of a prescription-event monitoring
study
D. Layton, L. Wilton and S. A. W. Shakir |
| R17
|
Development of an evidence-based
medication assessment tool to demonstrate the quality of drug therapy
use in patients with heart failure
J. McAnaw, S. Hudson and S. McGlynn |
| R18
|
Investigating the contribution of
community pharmacists in identifying, understanding and meeting the
needs of patients with diabetes, in collaboration with other healthcare
professionals
Ziba Rajaei-Dehkordi, Caroline Hollingshead, Donna Herkes, Michael Holden
and Shailen Rao |
| R19
|
Pharmacist-initiated MRSA eradication
therapy: benefits for patient care?
Paul E. Mills, Roberta Parnaby and Christine Clark
|
| R20
|
Supplying emergency hormonal contraception
in community pharmacies: variation according to mode of supply and
pharmacy type
E. M. Seston, R. A. Elliott and P. R. Noyce |
| R21
|
Eliciting women's preferences
for the supply of emergency hormonal contraception using discrete choice
techniques: identifying the attributes
E. M. Seston, R. A. Elliot and P. R. Noyce |
| R22
|
The validation of a medicines risk
assessment tool: a pilot study
Christopher Ranson, Ray Fitzpatrick, David Green, Claire Allen, Melvyn
Seed and Sue Lewis |
| R23
|
Medicines management in depression
may increase the length of antidepressant therapy in primary care
John Donoghue, Keith Farrar and Ann Slee |
| R24
|
The scope of literature on pharmacy
ethics
Joy Wingfield, Paul Bissell and Claire Anderson R24 |
| R25
|
Use of diphenhydramine as a non-prescription
hypnotic: patients' experiences
S. L. Barrington, R. Carroll, M. Hewitson, B. Munangatire, P. J. Rogers
and S. M. Wood |
| R26
|
The career intentions of primary
care pharmacists
R. Mullen |
| R27
|
Countdown to January 2005: standard
operating procedures, regulation, training and skill mix issues for
community pharmacy support staff
R. Mullen, S. Phul and J. Cantrill |
| R28
|
The attitude of a sample of community
pharmacists to the provision of medicines management
Elizabeth Dinnie, Christine Bond and Margaret Watson
|
| R29
|
Advantages of a pharmacist/nurse-led
lithium clinic with on-the-spot testing
Patricia Morgan |
| R30
|
The patient's approach to concordance:
a preliminary study
Caroline M. J. Allen, D. K. Raynor, Peter Knapp and Hilary Edmondson |
| R31
|
Medicines management in depression
changes the pattern of health care resource use by depressed patients
in primary care
John Donoghue, Keith Farrar and Ann Slee |
| R32
|
Does style matter? Assessing the
impact of two magazines about the menopause
J. Sowter, P. Knapp, M. Everett, E. Hartley, M. Griffith-Jones, J. Walker
and D. K. Raynor |
| R33
|
Evaluation of a pilot study to provide
a medicines information enquiry answering service based in secondary
care to general practitioners
Selwa El-Beik and Sue Banfield |
| R34
|
Attitudes to reflective practice
and continuing professional development
J. A. Rees, J. A. Cantrill, M. Morris, I. Smith and C. Watkins
|
| R35
|
How do general practitioners solve
medicine-related problems?
Kelly Alexander, Sue Banfield, Larissa Gent and Selwa El-Beik |
| R36
|
Training and development needs of
PCT strategic level pharmacists
Keith Wilson, Jill Jesson, Alison Blenkinsopp and Chris A. Langley |
| R37
|
An assessment of the alcohol content
of medicines commonly used in paediatric liver and cystic fibrosis
patients
C. M. Sanders, C. A. Langley, J. Persaud, J. F. Marriott and K. A. Wilson |
| R38
|
Financial consequences of one-stop
dispensing at Birmingham Children's Hospital
K. P. Seabridge, C. A. Langley, H. Sohal, J. F. Marriott and K. A. Wilson |
| R39
|
An investigation of how community
pharmacists solve medicines-related enquiries in South Manchester primary
care trust
Caroline Burgess, Selwa El-Beik, Ruth Murdoch, and Sue Banfield |
| R40
|
Opinions of community pharmacists
on their role in the prevention of cancer
E. F. R. Morrissey and C. Martin
|
| R41
|
A study of concordance issues for
older people
J. Westbury, K. Pollock and A. Blenkinsopp
|
| R42
|
Is psychoactive medication usage
in care homes related to staffing levels?
A. K. Schweizer, C. M. Hughes and M. L. Curran |
| R43
|
The effect of the prospective payment
system on antidepressant prescribing in United States nursing homes
Carmel M. Hughes and Kate L. Lapane
|
| R44
|
A qualitative study of issues relating
to adherence and concordance in hypertensive patients
C. Bane, M. Cupples, C. M. Hughes and J. C. McElnay
|
| R45
|
A retrospective evaluation of over-the-counter
drug-related contributions to overdose attendances at accident and
emergency departments in Northern Ireland
M. Wazaify, S. J. Kennedy, C. M. Hughes and J. C. McElnay
|
| R46
|
How many pharmacists are writing
discharge prescriptions in the north of England?
Sarah Parker, Carol Candlish, Lesley Davidson and Alan Worsley
|
| R47
|
Do pharmacists extemporaneously
dispense or do they use specials manufacturers?
C. A. Candlish, A. J. Worsley and S. Zaman
|
| R48
|
The inter-rater reliability of explicit
indicators of appropriate prescribing
M. P. Tully and J. A. Cantrill |
| R49
|
The validity of explicit indicators
of appropriateness of long term prescribing
M. P. Tully and J. A. Cantrill |
| R50
|
Community pharmacists' attitudes
and approaches to the Royal Pharmaceutical Society of Great Britain
continuing professional development initiatives
Helen Hull, Adrian Hunt and Paul Rutter |
| R51
|
Standardising risk assessment to
reduce unintentional non-compliance in aged patients pre-discharge
A. Donaghy and D. Wright |
| R52
|
The effects of patient personality
traits on relationships with health care professionals and on adherence
to medication regimens
Caroline Hughes, E. F. R. Morrissey, C. Purdy and J. C. McElnay
|
| R53
|
Development of a predictive model
to identify factors influencing uptake of celecoxib and esomeprazole
across primary care trusts
H. E. Kendall, S. Abbott and S. M. Jones |
| R54
|
A comparison of antibiotic prescribing
indicators and medicines management scoring in secondary care
C. Curtis, C. A. Langley, J. F. Marriott and K. A. Wilson |
| R55
|
Pharmaceutical care for older people
with mental health problems: what are the effects on adherence and
health?
D. Harris and C. Anderson |
| R56
|
Interventions by community pharmacists
for older people with mental health problems: are they appropriate?
D. Harris and C. Anderson |
| R57
|
Comparison of the incidence rates
of gastrointestinal and thromboembolic events reported for patients
prescribed celecoxib and meloxicam in general practice in England using
PEM data
Deborah Layton, Kerry Hughes, Scott Harris and Saad A. W. Shakir |
| R58
|
Comparison of the incidence rates
of thromboembolic events reported for patients prescribed rofecoxib
and meloxicam in general practice in England using prescription-event
monitoring data
Deborah Layton, Emma Heeley, Kerry Hughes and Saad A. W. Shakir |
| R59
|
Safety profile of raloxifene as
used in general practice in England: results of a prescription-event
monitoring study
D. Layton, L. Wilton and S. A. W. Shakir |
| R60
|
Effectiveness of inpatient oral
anticoagulation management: comparison of pharmacists with junior medical
staff
Keith Holden, Lynne Harris and Richard Prescott |
| R61
|
The relationship between a multiple
deprivation profile of general practitioners' practice lists and prescribing
M. G. Timoney, C. M. Hughes and J. C. McElnay |
| R62
|
Assessment of surface bioburden
during hospital aseptic processing
S. J. Hiom, C. Lowe and M. Oldcorne |
| R63
|
Pharmacist-led medication review
clinics in general practice: the views of Greater Glasgow GPs
F. MacRae, R. Lowrie, A. MacLaren, R. Barbour and J. Norrie
|
| R64
|
Nurse prescribers and community
pharmacists
Jason Hall, Judith Cantrill and Peter Noyce |
| R65
|
NHS consultation on patient privacy:
meeting the gap in the empirical evidence of pharmacists having access
to information
John Keane, Jill Jesson and Keith Wilson |
| R66
|
Older pharmacists in the Great Britain
pharmacy workforce: implications for professional practice
Phillip Shann and Karen Hassell
|
| R67
|
Unreported use of complementary
medicines by community pharmacy prescription customers
Swati Patel and Imogen Savage |
| R68
|
Is it time to stop dispensing extemporaneously
in community pharmacy?
S. M. Rennison and J. C. Portlock |
| R69
|
Is there clinical evidence of the
efficacy of medicinal products extemporaneously dispensed in community
pharmacies?
S. M. Rennison and J. C. Portlock
|
| R70
|
Medicine management for post myocardial
infarction and post coronary artery bypass graft patients: a retrospective
study
R. L. Loo and J. Kelly |
| R71
|
Outcomes guarantee: a new initiative
to reduce drug wastage in primary care
S. Chapman and E. Reeve |
| R72
|
Are angiotensin-converting enzyme
inhibitors prescribed appropriately and at evidence-based doses?
C. Alice Oborne and Kathryn McCormick |
| R73
|
Application of evidence-based criteria
of appropriate aspirin and appropriate lipid-lowering therapy in diabetic
inpatients
C. Alice Oborne and Marie Philbin |
| R74
|
Implementation of a clinic for pharmacist
review of hypertensive patients in primary care
F. Reid, P. Murray and M. Storrie |
| R75
|
Postgraduate training offered to
primary care pharmacists by schools of pharmacy: changes over the past
five years
C. A. Langley, J. K. Jesson, K. A. Wilson and A. Blenkinsopp |
| R76
|
Enhancing the pharmaceutical care
of patients with atrial fibrillation
S. J. Tweddell, D. J. Wright, C. Acomb and P. Taylor
|
| R77
|
The attitudes and readiness of independent
community pharmacists towards electronic transfer of prescriptions
G. Hall, S. M. Hall and M. Patel |
| R78
|
Extemporaneous manipulation of drugs
in a paediatric hospital pharmacy: an audit
Catherine Tuleu, Joana Marques, Vincent Yeung and Ian Wong |
| R79
|
Oral syringe use in an acute hospital:
audit and policy introduction
Tracey Boyce |
| R80
|
Developing a coronary heart disease
service from a community pharmacy
Francois Joubert and Gary Choo |
| R81
|
An audit on the prescribing of atypical
antipsychotics in a primary care trust to investigate compliance with
licensing and NICE and PCT guidelines
C. Stewart, I. J. Cubbin, A. Munyika and T. Hinstridge
|
| R82
|
A drug evaluation of the prescribing
of COX-2 inhibitors in a local PCT compared with local and national
guidelines
F. Ahmed, I. J. Cubbin and T. Hinstridge |
| R83
|
Research needs analysis: collaborative
working towards a proactive research culture in pharmacy and the therapy
professions in South Tees
P. A. Walters and A. Birleson |
| R84
|
Neyland Pharmacy: healthy lifestyle
clinic
J. David and S. J. Hiom |
| R85
|
Benchmarking the current dispensing
rate of Welsh hospital pharmacies
S. Hiom, D. Roberts, M. Hawksbee, R. Burfield, M. Francis, K. Walker, S.
Lord and N. Warner |
| R86
|
When do medication errors occur
and who reports them? Analysis of a web-based incident reporting scheme
in secondary care
D. M. Ashcroft, M. Birtwistle, J. Cooke, K. Hingley and P. Moore |
| R87
|
One-stop or non-stop? Assessing
the benefits of near-patient dispensing on a general medical ward
Debbie Campbell, Clare Conroy, Tanya Cameron and Mary Nicholls |
| R88
|
Switching elderly patients from
NSAIDs to paracetamol: do patients accept it and does the switch method
make a difference?
Judith East, Imogen Savage and Michael Blinston-Jones |
| R89
|
Influences on the prescribing of
general practitioners: a cluster analysis
K. Aström, C. Duggan and I. Bates
|
| R90
|
Clinical medication review by a
pharmacist for older people in care homes: preliminary report
D. P. Alldred, A. G. Zermansky, D. R. Petty, D. K. Raynor, S. Thornton,
N. Freemantle, J. Eastaugh and P. Bowie |
| R91
|
Competency framework improves the
clinical practice of junior hospital pharmacists: interim results of
the south of England trial
D. G. Webb, J. G. Davies, I. P. Bates, D. McRobbie, S. Antoniou, J. Wright
and J. Quinn |
| R92
|
Managing medicines: a social worlds
perspective of professional involvement
S. Simpson Prentis, K. Atkin, D. K. Raynor and S. J. Closs |
| R93
|
Blessed are the decision-makers?
Approaches to decision-making in prescribing
J. Hackwood, D. K. Raynor and P Knapp |
| R94
|
Exploring antibiotic use using geographical
information systems technology
G. Becket, D. Ecke, K. M. Ryan and P. T. Norris |
| R95
|
Role of the community pharmacist
in health care needs for members of the south Asian minority ethnic
population: general practitioner perspective
Role of the community pharmacist in health care needs for members of the
south Asian minority ethnic population: general practitioner perspective |
| R96
|
Children's over-the-counter medicines
purchase evaluation (COPE)
Ian Wong, Siew Siang Chua, Hilary Edmondson and Joana Marques |
| R97
|
Medication review: recruitment and
accreditation of a cohort of community pharmacists
A. G. MacLaren, C. A. Mackie, R. Lowrie and S. Tennant |
| R98
|
Evidence of safety used to support
decisions to withdraw medicinal products from the UK and US markets
Andrea Clarke and Saad A. W. Shakir |
| R99
|
The impact of reflection on clinical
pharmacy practice: initial findings
J. Swart, A. Taylor and D. Taylor |
|
4 (first) 10 20 30 40 50 60 70 80 90 99 (last) |
